Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 62,700 | 82,600 | 51,800 | 62,870 | 36,741 |
| Depreciation Amortization | 63,100 | 44,300 | 38,200 | 35,335 | 32,453 |
| Income taxes - deferred | 8,600 | 3,300 | 5,200 | 3,464 | 16,493 |
| Accounts receivable | -94,200 | -4,800 | -22,400 | -64,351 | 21,405 |
| Accounts payable and accrued liabilities | -7,000 | 16,100 | -14,800 | 4,749 | -9,279 |
| Other Working Capital | -119,300 | 53,700 | -44,300 | -67,846 | 13,541 |
| Other Operating Activity | 127,900 | 12,900 | 40,900 | 68,296 | 964 |
| Operating Cash Flow | $41,800 | $208,100 | $54,600 | $42,517 | $112,318 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -69,500 | -54,800 | -76,200 | -44,812 | -30,673 |
| Net Acquisitions | -827,700 | -195,100 | N/A | -650 | -179,379 |
| Investing Cash Flow | $-897,200 | $-249,900 | $-76,200 | $-45,462 | $-210,052 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 798,000 | 0 | 0 | 2,000 | 242,588 |
| Debt Repayment | -2,800 | 0 | 0 | N/A | -62,000 |
| Common Stock Issued | N/A | 19,300 | 17,100 | 25,961 | 14,078 |
| Common Stock Repurchased | -100 | -33,100 | 0 | -100 | -200 |
| Other Financing Activity | -6,400 | -37,600 | -36,900 | 7,530 | 4,408 |
| Financing Cash Flow | $788,700 | $-51,400 | $-19,800 | $35,391 | $198,874 |
| Exchange Rate Effect | -200 | 0 | 100 | -150 | 21 |
| Beginning Cash Position | 179,300 | 272,500 | 312,800 | 280,499 | 179,338 |
| End Cash Position | 112,400 | 179,300 | 271,500 | 312,795 | 280,499 |
| Net Cash Flow | $-66,900 | $-93,200 | $-41,300 | $32,296 | $101,161 |
| Free Cash Flow | |||||
| Operating Cash Flow | 41,800 | 208,100 | 54,600 | 42,517 | 112,318 |
| Capital Expenditure | -72,100 | -54,800 | -76,200 | -44,812 | -30,673 |
| Free Cash Flow | -30,300 | 153,300 | -21,600 | -2,295 | 81,645 |